Pal­isade Bio is the lat­est to re­struc­ture, hun­ker­ing down on its lead pro­gram

Like so many oth­er biotechs in the bear mar­ket, Pal­isade Bio is look­ing to play the re­org game and lay off parts of its staff.

The Carls­bad, CA-based biotech an­nounced on Thurs­day that it will be putting a se­ries of mea­sures in place to “re­duce op­er­at­ing ex­pens­es and pre­serve cap­i­tal.” Pal­isade Bio CEO Tom Hal­lam said in a state­ment that due to cur­rent mar­ket con­di­tions, and to en­sure that it push­es for­ward in de­vel­op­ing its lead can­di­date, 20% of the work­force will be let go.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER